Abstract
Epidemiological studies have shown that human leukocyte antigen (HLA) allelic polymorphisms are closely correlated to susceptibility to nasopharyngeal carcinoma (NPC), and in a previous study, we showed that HLA-B*46 and HLA-A*02-B*46 haplotypes were strongly associated with NPC susceptibility. In this retrospective study, we investigated the phenotype of the HLA-A and HLA-B alleles and haplotypes and correlated these data to the clinical and pathological parameters of NPC to understand the role of HLA alleles and haplotypes in NPC prognosis. The cohort comprised 117 NPC patients from a Han population in Xinjiang. The local recurrence-free survival (LRFS), distant metastasis- free survival (DMFS), disease-free survival (DFS), and overall survival (OS) were analyzed. The 5-year DMFS of the HLA-A*02-B*46 haplotype carriers and non-carriers was 66.4% and 90.3%, respectively. In addition, age was found to be a prognostic factor for LRFS, DFS, and OS (P=0.032, 0.040, and 0.013, respectively). We found that the HLA-A*02-B*46 haplotype might be a prognostic marker in addition to the traditional TNM staging in patients with NPC.
Similar content being viewed by others
References
Tang MZ, Cai YL, Zheng YM, et al. Association between human leukocyte antigen and nasopharyngeal carcinoma. Yi Chuan (Chinese), 2012,34(12):1505–1512
Horton R, Wilming L, Rand V, et al. Gene map of the extended human MHC. Nat Rev Genet, 2004,5(12):889–899
Chin YM, Mushiroda T, Takahashi A, et al. HLA-A SNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese. Int J Cancer, 2015,136(3):678–687
Yu KJ, Gao X, Chen CJ, et al. Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Hum Immunol, 2009,70(11):910–914
Tang M, Zeng Y, Poisson A, et al. Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population. Genes Immun, 2010,11(4):334–342
Wang R, Hu Y, Yindom LM, et al. Association analysis between HLA-A, -B, -C, -DRB1, and-DQB1 with nasopharyngeal carcinoma among a Han population in Northwestern China. Hum Immunol, 2014,75(3):197–202
Lin Z, Guo Z, Xu Y, et al. Identification of a secondary promoter of CASP8 and its related transcription factor PURa. Int J Oncol, 2014,45(1):57–66
Luo RZ, Zhong BL, Zong YS, et al. Histopathological characteristics of nasopharyngeal carcinoma in high incidence areas. Chin J Cancer (Chinese), 2001,20(8):473–475
Tang M, Lautenberger JA, Gao X, et al. The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet, 2012,8(11):e1003103
Yuan J, Liu S, Yu Q, et al. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma. Acta Histochem, 2013,115(5):470–474
Minami T, Minami T, Shimizu N, et al. Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma. Int Immunopharmacol, 2014,20(1):59–65
Tertipis N, Villabona L, Nordfors C, et al. HLA-A*02 in relation to outcome in human papillomavirus positive tonsillar and base of tongue cancer. Anticancer Res, 2014,34(5):2369–2375
Simons MJ, Chan SH, Wee GB, et al. Nasopharyngeal carcinoma and histocompatibility antigens. IARC Sci Publ, 1978,20:271–382
Hildesheim A, Apple RJ, Chen CJ, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst, 2002,94(23):1780–1789
Hu SP, Day NE, Li DR, et al. Further evidence for an HLA related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer, 2005,92(5):967–970
Lu CC, Chen JC, Jin YT, et al. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese. Int J Cancer, 2003,103(6):745–751
Sengupta S, den Boon JA, Chen IH, et al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res, 2006,66(16):7999–8006
Han L, Lin SJ, Pan JJ, et al. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chin J Cancer (Chinese), 2010,29(2):145–150
Author information
Authors and Affiliations
Corresponding author
Additional information
This project was supported by grants from the Chinese International Cooperation Project (No. 2012DFA31560), Key Laboratory Projects of Xinjiang Uygur Autonomous Region (No. 2015KL021), and the Achievement Promotion Projects of the Autonomous Region (No. 201554142).
Rights and permissions
About this article
Cite this article
Wang, Rz., Zhang, Dg., Wu, R. et al. HLA-A*02-B*46 haplotype: an adverse prognostic factor in Han patients with nasopharyngeal carcinoma. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 36, 700–704 (2016). https://doi.org/10.1007/s11596-016-1647-y
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-016-1647-y